If you are at #AAGConf22 check out Laura Dowd poster on #opioid prevalence in Australian #RACFs AAG CMUS

People living with #dementia and mild cognitive impairment are generally willing to have one of their medications #deprescribed Read more here: doi.org/10.1093/ageing… CMUS Johns Hopkins Geriatric Medicine & Gerontology Kaiser Permanente CO Monash Institute of Pharmaceutical Sciences Cynthia Boyd

Dementia has overtaken coronary heart disease as the leading cause of disease burden among Australians aged 65 and over. See more: fal.cn/3w4x4 #Dementia #HeartDisease BurdenEU Dementia Australia Australian Chronic Disease Prevention Alliance Heart Foundation

1 in 3 aged care residents may benefit from analgesic review. More evidence for need for #embedded #onsite #pharmacists in aged care!! Laura Dowd CMUS doi.org/10.1007/s40266…

Nice work Laura Dowd ... Identifying residents who may benefit from analgesic review: applying analgesic indicators in residential #AgedCare services. Drugs Aging (2023). #medicinesafety #analgesicstewardship doi.org/10.1007/s40266…

A multidisciplinary analgesic stewardship approach may optimise pain management plans and reduce opioid usage in RACF residents. #agedcare #opioidstewardship onlinelibrary.wiley.com/doi/abs/10.111…

Congratulations to our 3 amazing PhD students who presented at today's CMUS milestone event. Laura Dowd on #analgesic use in #agedcare, Stella Kim on antiseizure meds post #stroke, LouiseLord on medication use & mental health in #cysticfibrosis. Monash Institute of Pharmaceutical Sciences

Two CMUS superstars presenting at #IAGG23 in Yokohama (Japan). Laura Dowd comparing #analgesic use in Aus and Japan #agedcare. Shin Liau comparing symptomatic and preventive medication use in Aus and Japan #agedcare. Monash Institute of Pharmaceutical Sciences

Excited to share my work regarding onsite #agedcare #pharmacists and #knowledgebrokers at #IAGG23 in Yokohama (Japan)! CMUS Monash Institute of Pharmaceutical Sciences

Amazing day of cross-national learning with CMUS and Japanese colleagues at Uni of Tokyo. We discussed our #agedcare systems & opportunities to share initiatives and setup new projects. We also visited a Japanese medical clinic & nursing home! Monash Institute of Pharmaceutical Sciences

I’ve had an amazing week in #Japan attending the #IAGG23 conference, connecting with our amazing Japanese collaborators and attending the baseball with CMUS colleagues! Feeling very grateful and inspired after this experience 🇯🇵#agedcare Monash Institute of Pharmaceutical Sciences Amanda Cross

📜Have you written your abstract for the 2023 Australian Deprescribing Network (ADeN) annual meeting yet? ⏰Submissions close 30th of September! ℹ️ Follow this link for more information tinyurl.com/52ed3ydw 👀We can't wait to see you there!

Find out more about analgesic and adjuvant use in Aus and Finnish nursing homes at #EuGMS2023 Laura Dowd Amanda Cross CMUS Shin Liau

👋We look forward to seeing you at the Australian Deprescribing Network (ADeN) 2023 Meeting on November 3rd! 👉Please remember to register for this event: eventbrite.com/e/australian-d… 👉Check out the conference program here: australiandeprescribingnetwork.com.au/wp-content/upl…

CMUS researchers have found 74% of Australia’s aged care population are prescribed regular painkiller medications and are 30 times more likely to use opioids, compared to Japan. Published in Age_and_Ageing. #MonashPharm #ChangeIt #Research monash.edu/pharm/about/ne…

Over 90% of #frail #nursinghome residents in 🇦🇺🇨🇳🇯🇵🇪🇸 who were most vulnerable to medication #sideeffects were prescribed #medications that may cause harm based on the #STOPPFrail criteria It's time to consider #deprescribing to optimise #medicationuse 🔖bit.ly/frailnh

Excited to share our mixed-methods study on the pharmacological management of #pain in Australian & Japanese #nursinghomes. Huge differences in #analgesic use + some different approaches to pain management between countries Laura Dowd CMUS academic.oup.com/ageing/article…

Our cross-national comparison of #analgesic use in Australian & Japanese RACFs🌎. Reasons for the huge (i.e. 30-fold) discrepancy in #opioid use may include: ❔Differences in pain assessment ❔Regulations/Restrictions ❔Treatment durations Read here: academic.oup.com/ageing/article…